Marksans Pharma completes acquisition of manufacturing site from Tevapharm India

Marksans will continue to supply existing products until the end of 2023 to Teva's affiliates, ensuring high-quality standards

FDA accepts application for Merck’s Keytruda plus chemotherapy as first-line treatment for metastatic gastric

Acceptance based on results from the Phase 3 KEYNOTE-859 trial, which showed significant overall survival benefit in these patients with HER2-negative disease, regardless of PD-L1 expression

DG, ICMR and Director CSIR-NIScPR release special issues of Vigyan Pragati & Science Reporter magazines

Science communication brings behavioural changes

Astec LifeSciences launches Rs. 100 crore Adi Godrej Center for Chemical Research and Development

To enable company to be future-ready by tapping potential in CDMO space

AIIA hosts walkthrough for Working Group of C20 on Integrated Holistic Health

MoU signed between AIIA and University of Amrita Vishwa Vidhyapeetham for collaboration in the field of Research and Academics in Ayurveda

Thermo Fisher Scientific expands its capabilities in France

Bourgoin early development hub broadens offerings for oral solid dose formulations

Cognizant, Microsoft collaborate to bring cloud-based solutions to the healthcare market

Microsoft Cloud for Healthcare and Cognizant’s TriZetto healthcare products aim to enhance transparency for consumers and increase interoperability for providers and payers

Inflation and declining FDA drug approvals will pose challenges for pharma contract manufacturers in 2023, says GlobalData

FDA’s NME approvals declined substantially in 2022, causing overall New Drug Application (NDA) approvals to drop

Zydus receives final approval from the USFDA for Acetazolamide Tablets

Acetazolamide is used to treat glaucoma

SK Capital completes acquisition of Apotex